425: Strive & Semler Scientific Merger: Cautionary Update

Strive, Inc. and Semler Scientific, Inc. issue a cautionary statement regarding their proposed business combination, highlighting inherent risks and uncertainties.

Summary

• This communication, reposted by Strive Board Member Pierre Rochard on October 31, 2025, relates to the proposed business combination between Strive, Inc. and Semler Scientific, Inc.
• It serves as a cautionary statement regarding forward-looking statements, emphasizing that actual results could differ materially from expectations due to various risks and uncertainties.
• Strive intends to file a Registration Statement on Form S-4 with the SEC, which will include an Information Statement/Proxy Statement/Prospectus.
• Semler Scientific stockholders will be asked to approve the proposed transaction based on information provided in the forthcoming documents.

Sentiment

Score: 4

Explanation: The filing is primarily a cautionary statement regarding a proposed merger, emphasizing numerous risks and uncertainties. While it relates to a significant corporate event, the tone is heavily focused on potential negative outcomes and legal disclaimers, leading to a neutral to slightly cautious sentiment.

Risks

• The occurrence of any event, change, or circumstance that could give rise to the right of either Strive or Semler Scientific to terminate the merger agreement.
• The possibility that the proposed transaction does not close when expected or at all because conditions to closing are not received or satisfied on a timely basis.
• The outcome of any legal proceedings that may be instituted against Strive, Semler Scientific, or the combined company.
• Anticipated benefits of the proposed transaction, including cost savings and strategic gains, may not be realized, potentially due to changes in Bitcoin treasury strategies and risks associated with digital assets.
• Integration of the two companies may be more difficult, time-consuming, or costly than expected.
• The proposed transaction may be more expensive or take longer to complete than anticipated due to unexpected factors or events.
• Diversion of management's attention from ongoing business operations and opportunities.
• Dilution caused by Strive's issuance of additional shares of its Class A common stock in connection with the proposed transaction.
• Potential adverse reactions of Strive's or Semler Scientific's customers or changes to business or employee relationships resulting from the announcement or completion of the transaction.
• Changes in Strive's or Semler Scientific's share price before closing.
• General economic and market conditions, interest and exchange rates, monetary policy, and changes in laws and regulations and their enforcement.
• Other unknown or unpredictable factors could also harm Strive, Semler Scientific, or the combined company's results.

Future Outlook

The filing contains numerous forward-looking statements regarding the proposed transaction, including expectations for strategic and financial benefits, the timing of closing, and the ability to successfully integrate the combined businesses. However, these are subject to significant risks and uncertainties, and there is no assurance that actual results will not differ materially from projections.

Industry Context

The filing does not provide specific industry context or analysis beyond mentioning risks associated with Bitcoin and other digital assets, which suggests a potential strategic shift or emphasis on digital asset treasury strategies for the combined entity, a trend seen in some companies seeking to diversify or hedge against traditional financial systems.

Stakeholder Impact

• Shareholders of Strive: Potential dilution due to the issuance of additional Class A common stock.
• Customers of Strive and Semler Scientific: Potential adverse reactions or changes to business relationships.
• Employees of Strive and Semler Scientific: Potential changes to employee relationships.

Next Steps

• Strive intends to file a Registration Statement on Form S-4 with the SEC to register the Class A common stock to be issued.
• The Registration Statement will include an Information Statement of Strive, a proxy statement of Semler Scientific, and a prospectus of Strive.
• A definitive Information Statement/Proxy Statement/Prospectus will be sent to the stockholders of Semler Scientific.
• Stockholders of Semler Scientific will be asked to approve the proposed transaction.

Key Dates

Keywords

Strive Inc, Semler Scientific Inc, Merger, Business Combination, SEC Filing, Form 425, Forward-Looking Statements, Risk Factors, Corporate Governance, Bitcoin Treasury, Digital Assets